Dunnione restored reduced SIRT1 activity in lung tissues of tumor-bearing mice by augmentation of NAD+, thus deacetylating NF-κB and reducing NF-κB activity, resulting in decreased TF expression and activity. Here, NFKB1 is linked to neoplasm.